Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer organoids: A platform in basic and translational research
Xin Ma, Qin Wang, Guozheng Li, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 614-632
Open Access | Times Cited: 20

Showing 20 citing articles:

From LncRNA to metastasis: The MALAT1-EMT axis in cancer progression
Riya Thapa, Obaid Afzal, Muhammad Afzal, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 154959-154959
Closed Access | Times Cited: 50
Biomimetic Scaffolds—A Novel Approach to Three Dimensional Cell Culture Techniques for Potential Implementation in Tissue Engineering
Tomasz Górnicki, Jakub Lambrinow, Afsaneh Golkar‐Narenji, et al.
Nanomaterials (2024) Vol. 14, Iss. 6, pp. 531-531
Open Access | Times Cited: 22
Novel clinical trial designs emerging from the molecular reclassification of cancer
Mina Nikanjam, Shumei Kato, Teresa Allen, et al.
CA A Cancer Journal for Clinicians (2025)
Open Access | Times Cited: 3
Crosstalk and communication of cancer-associated fibroblasts with natural killer and dendritic cells: New frontiers and unveiled opportunities for cancer immunotherapy
Simone Ielpo, Francesca Barberini, Farnaz Dabbagh Moghaddam, et al.
Cancer Treatment Reviews (2024) Vol. 131, pp. 102843-102843
Open Access | Times Cited: 7
The Transformative Role of 3D Culture Models in Triple-Negative Breast Cancer Research
Xavier S. Bittman‐Soto, Evelyn S. Thomas, Madeline Ganshert, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1859-1859
Open Access | Times Cited: 4
Tumor organoids in cancer medicine: from model systems to natural compound screening
Rong Cong, Can Lu, Xinying Li, et al.
Pharmaceutical Biology (2025) Vol. 63, Iss. 1, pp. 89-109
Open Access
Inhibition of Stemness and PD-L1 Expression by Pien Tze Huang Enhances T Cell-Mediated Killing of Colorectal Cancer
Qin Lu, Zhuqing Zhang, Sihan Liu, et al.
Journal of Ethnopharmacology (2025), pp. 119447-119447
Closed Access
Basic Science, New Target Investigation, and Research in Childhood Cancer
Hafeez Abdelhafeez, Victor M. Santana
(2025), pp. 1-6
Closed Access
Innovative Construction and Application of Bile Duct Organoids: Unraveling the Complexity of Bile Duct Diseases and Potential Therapeutic Strategies
Yadi Geng, Ziye Chen, Tianzi Luo, et al.
Cancer Letters (2025), pp. 217619-217619
Closed Access
Cell culture techniques for cancer research
Preeti Jain, N. V. Joshi, Sadhna Aggarwal
Methods in cell biology (2025)
Closed Access
Patient-derived esophageal adenocarcinoma organ chip: a physiologically relevant platform for functional precision oncology
Sanjima Pal, Elee Shimshoni, Salvador Flores Torres, et al.
Research Square (Research Square) (2025)
Closed Access
Organoid models in bladder cancer: From bench to bedside?
Hongda Zhao, Vincy Wing Sze Ho, Kang Liu, et al.
Bladder Cancer (2025) Vol. 11, Iss. 2
Open Access
Management strategies for primary lung carcinosarcoma: a case study and comprehensive literature review
Zhonglian Wang, Ying Zeng, Hua Jiang, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 4
Open Access
Organoid morphology-guided classification for oral cancer reveals prognosis
Mi Rim Lee, Sumin Kang, Jonghyun Lee, et al.
Cell Reports Medicine (2025), pp. 102129-102129
Open Access
Tumor Organoids: The Era of Personalized Medicine
Natalia V Rassomakhina, A. Yu. Ryazanova, Astemir R. Likhov, et al.
Biochemistry (Moscow) (2024) Vol. 89, Iss. S1, pp. S127-S147
Closed Access | Times Cited: 3
Patient-Derived Organoids: A Game-Changer in Personalized Cancer Medicine
Mohammad Hadi Abbasian, Navid Sobhani, Mahsa Mollapour Sisakht, et al.
Stem Cell Reviews and Reports (2024)
Closed Access | Times Cited: 3
Organoid models of breast cancer in precision medicine and translational research
Vahid Niazi, Benyamin Parseh
Molecular Biology Reports (2024) Vol. 52, Iss. 1
Closed Access | Times Cited: 1
Advances in the application of colorectal cancer organoids in precision medicine
Yanan Zhang, Ruoyu Meng, Dan Sha, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Liensinine diperchlorate and artemisitene synergistically attenuate breast cancer progression through suppressing PI3K-AKT signaling and their efficiency in breast cancer patient-derived organoids
Xian Lin, Tengyu Lin, Meng Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116871-116871
Open Access
Patient-derived organoids from pancreatic cancer after pancreatectomy: feasibility and organoid take rate in treatment-naïve periampullary tumors
Marcus Roalsø, Marina Alexeeva, Celine Oanæs, et al.
Pancreatology (2024)
Open Access
Breast Cancer Tissue Explants: An Approach to Develop Personalized Therapy in Public Health Services
Pilar Carranza‐Rosales, Daniel Valencia-Mercado, Olga Esquivel-Hernández, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 10, pp. 1521-1521
Open Access
Page 1

Scroll to top